Suppr超能文献

核心雌激素受体(ER)检测与切除肿瘤的比较:乳腺癌中ER的瘤内分布

Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma.

作者信息

Douglas-Jones A G, Collett N, Morgan J M, Jasani B

机构信息

Department of Pathology, University of Wales College of Medicine, Heath Park, Cardiff, South Glamorgan, CF14 4XN, UK.

出版信息

J Clin Pathol. 2001 Dec;54(12):951-5. doi: 10.1136/jcp.54.12.951.

Abstract

AIMS

The use of the H score (involving the assessment of intensity and distribution of positivity) on sections stained for the oestrogen receptor (ER) by immunocytochemistry (ICC) allows different samples to be compared and detailed correlations to be made between hormone receptor expression and morphology. This study assessed the reliability of core biopsy in predicting ER expression in the same tumour excised later at treatment. The distribution of ER within excised tumours was investigated.

METHODS

The distribution of ER positivity was investigated in 51 diagnostic core biopsies and across the diameter of 51 subsequently excised tumours in a field by field (magnification, x40; field diameter, 0.4 mm) assessment using the semiquantitive H scoring system.

RESULTS

The ER H score in diagnostic core biopsy was significantly higher (p = 0.05, paired rank test; overall mean, 130; n = 51) than the mean in the corresponding excised tumour (mean, 110; n = 51). There was a significant downward trend in ER positivity from the periphery of tumours towards the centre (p = 0.001). The reduction of ER positivity was 6 H score units (2%)/mm. If core biopsies were orientated with the tumour edge at one end no change in ER positivity with field number along the length of the core could be demonstrated.

CONCLUSIONS

ER estimation in core biopsies correlated well with expression in tumours but ER expression was higher in the core biopsies than in the excised tumours. ER expression was higher at the periphery of tumours than at the centre. The higher ER expression in cores may reflect the higher chance of sampling the peripheral part of a tumour using a needle core.

摘要

目的

通过免疫细胞化学(ICC)对雌激素受体(ER)染色切片使用H评分(涉及阳性强度和分布的评估),可以比较不同样本,并在激素受体表达与形态之间建立详细的相关性。本研究评估了粗针活检在预测后续治疗时切除的同一肿瘤中ER表达的可靠性。研究了切除肿瘤内ER的分布情况。

方法

使用半定量H评分系统,逐视野(放大倍数,×40;视野直径,0.4mm)评估51例诊断性粗针活检中ER阳性的分布情况以及随后切除的51个肿瘤的直径范围。

结果

诊断性粗针活检中的ER H评分显著高于相应切除肿瘤中的平均值(p = 0.05,配对秩和检验;总体均值,130;n = 51)(平均值,110;n = 51)。从肿瘤周边向中心,ER阳性呈显著下降趋势(p = 0.001)。ER阳性的降低为6个H评分单位(2%)/mm。如果粗针活检以肿瘤边缘一端为方向,则沿针芯长度的视野中ER阳性不会随视野数量而改变。

结论

粗针活检中的ER估计与肿瘤中的表达相关性良好,但粗针活检中的ER表达高于切除的肿瘤。肿瘤周边的ER表达高于中心。粗针中较高的ER表达可能反映了使用针芯采样肿瘤周边部分的机会更高。

相似文献

5
Oestrogen receptor assay of breast cancer by immunocytochemistry of fine needle aspirates.
Aust N Z J Surg. 1991 Mar;61(3):223-8. doi: 10.1111/j.1445-2197.1991.tb07596.x.
8
Immunochemistry for oestrogen receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma.
Cytopathology. 2012 Jun;23(3):181-6. doi: 10.1111/j.1365-2303.2011.00853.x. Epub 2011 Mar 6.
9
Comparison of four immunochemical methods for the measurement of oestrogen receptor levels in breast cancer.
Cytopathology. 1992;3(3):155-60. doi: 10.1111/j.1365-2303.1992.tb00041.x.
10
[Expression of oestrogen receptor-beta in invasive breast tumours].
Magy Onkol. 2004;48(1):63-9. Epub 2004 Apr 23.

引用本文的文献

2
Diagnostic value of core needle biopsy for determining HER2 status in breast cancer, especially in the HER2-low population.
Breast Cancer Res Treat. 2023 Jan;197(1):189-200. doi: 10.1007/s10549-022-06781-3. Epub 2022 Nov 8.
3
Intratumoral Heterogeneity of Expression of 16 miRNA in Luminal Cancer of the Mammary Gland.
Noncoding RNA. 2020 May 11;6(2):16. doi: 10.3390/ncrna6020016.
5
Assessment of the Spatial Heterogeneity of Breast Cancers: Associations Between Computed Tomography and Immunohistochemistry.
Biomark Cancer. 2019 Jun 4;11:1179299X19851513. doi: 10.1177/1179299X19851513. eCollection 2019.
6
Tumor Pre-Analytics in Molecular Pathology: Impact on Protein Expression and Analysis.
Curr Pathobiol Rep. 2018;6(4):265-274. doi: 10.1007/s40139-018-0179-5. Epub 2018 Sep 6.
7
Improving accuracy of breast cancer biomarker testing in India.
Indian J Med Res. 2017 Oct;146(4):449-458. doi: 10.4103/ijmr.IJMR_896_16.
10
Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification.
Breast Cancer Res. 2016 Jun 28;18(1):68. doi: 10.1186/s13058-016-0725-1.

本文引用的文献

3
Estrogen and progesterone receptor contents in ThinPrep-processed fine-needle aspirates of breast.
Am J Clin Pathol. 1999 Jul;112(1):50-6. doi: 10.1093/ajcp/112.1.50.
4
Changing to core biopsy in an NHS breast screening unit.
Clin Radiol. 1997 Oct;52(10):764-7. doi: 10.1016/s0009-9260(97)80156-0.
5
Cytological evaluation of biological prognostic markers from primary breast carcinomas.
Breast Cancer Res Treat. 1997 May;44(1):65-74. doi: 10.1023/a:1005717924761.
8
Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer.
Cancer. 1980 Dec 15;46(12 Suppl):2889-95. doi: 10.1002/1097-0142(19801215)46:12+<2889::aid-cncr2820461430>3.0.co;2-4.
9
Intratumoral variation of cytoplasmic and nuclear estrogen receptor concentrations in human mammary carcinoma.
Eur J Cancer (1965). 1980 Jan;16(1):59-65. doi: 10.1016/0014-2964(80)90108-5.
10
Estrogen receptor assay on breast cancer microsamples: implications of percent carcinoma estimation.
Cancer. 1982 Jun 1;49(11):2383-8. doi: 10.1002/1097-0142(19820601)49:11<2383::aid-cncr2820491127>3.0.co;2-g.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验